Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs

Author： Norman Peter  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.23, Iss.1, 2014-01, pp. : 55-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DP2 receptor antagonists in development

By Norman Peter  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 947-961

Informa Healthcare

Access to resources Recommend Favorite

δ-Opioid Receptor Antagonists as a New Concept for Central Acting Antitussive Drugs

By Kamei J.  

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 3, 2002-06 ,pp. : 235-240

Academic Press

Access to resources Recommend Favorite

Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential

By  

Current Medicinal Chemistry, Vol. 22, Iss. 6, 2015-02 ,pp. : 713-729

Bentham Science Publishers

Access to resources Recommend Favorite

An update on the status of endothelin receptor antagonists for hypertension

By Dao Huy Hao   Moreau Pierre  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1937-1946

Informa Healthcare

Access to resources Recommend Favorite

The use of DP receptor antagonists to treat allergic rhinitis

By  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 597-599

Informa Healthcare

Access to resources Recommend Favorite